Catalysts for Fougera Pharmaceuticals Inc
9 tracked
Mar 3, 2026
approval
FLUTICASONE PROPIONATE — FDA approval
Fougera Pharmaceuticals Inc
→
Feb 24, 2026
approval
MUPIROCIN — FDA approval
Fougera Pharmaceuticals Inc
→
Feb 24, 2026
approval
MUPIROCIN — FDA approval
Fougera Pharmaceuticals Inc
→
Feb 24, 2026
approval
MUPIROCIN — FDA approval
Fougera Pharmaceuticals Inc
→
Jan 12, 2026
approval
FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (FLUTICASONE PROPIONATE) — FDA approval
Fougera Pharmaceuticals Inc
→
Dec 10, 2025
approval
MOMETASONE FUROATE — FDA approval
Fougera Pharmaceuticals Inc
→
Oct 31, 2015
approval
MOMETASONE FUROATE — FDA approval
Fougera Pharmaceuticals Inc
→
Nov 30, 2005
approval
MUPIROCIN — FDA approval
Fougera Pharmaceuticals Inc
→
Mar 28, 2005
approval
MOMETASONE FUROATE — FDA approval
Fougera Pharmaceuticals Inc
→